PMVP

NASDAQ · Biotechnology

Pmv Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.04

+0.02 (+1.96%)

As of Feb 8, 2:17 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +569.2% upside

Low Target $5.52

Average Target $6.96

High Target $10.50

Current Price $1.04

Current
$1.04

Target
$6.96

$5.52 $6.96 avg $10.50

Scenario Analysis

Bear Case

$5.52

430.8%

Low target

Base Case

$6.96

+569.2%

Avg target

Bull Case

$10.50

+909.6%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$6.41

-83.8% from high

52-Week Low

$4.32

+-75.9% from low

Target vs 52W High

$6.96

+8.6% vs high

Next Earnings Report

Mar 4, 2026 · After Market Close

16d

until earnings

EPS Est: $-0.41

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%